These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36301437)

  • 1. Barriers for Participation in the Danish Colorectal Cancer Screening Program: a Qualitative Study.
    Phillipsen S; Weltz LK; Dressler J; Nielsen MK; Rasmussen M; Jorgensen LN; Johnsen AT
    J Gastrointest Cancer; 2023 Sep; 54(3):873-881. PubMed ID: 36301437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, Attitudes, and Beliefs About Colorectal Cancer Screening in Puerto Rico.
    Colón-López V; Valencia-Torres IM; Ríos EI; Llavona J; Vélez-Álamo C; Fernández ME
    J Cancer Educ; 2023 Apr; 38(2):552-561. PubMed ID: 35359256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in attitudes impeding colorectal cancer screening.
    Ritvo P; Myers RE; Paszat L; Serenity M; Perez DF; Rabeneck L
    BMC Public Health; 2013 May; 13():500. PubMed ID: 23706029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
    Nielsen JB; Berg-Beckhoff G; Leppin A
    BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for participation and non-participation in colorectal cancer screening.
    Berg-Beckhoff G; Leppin A; Nielsen JB
    Public Health; 2022 Apr; 205():83-89. PubMed ID: 35248951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review.
    Dressler J; Johnsen AT; Madsen LJ; Rasmussen M; Jorgensen LN
    Public Health; 2021 Jan; 190():67-74. PubMed ID: 33360029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stitch in time saves nine: Perceptions about colorectal cancer screening after a non-cancer colonoscopy result. Qualitative study.
    Kirkegaard P; Edwards A; Andersen B
    Patient Educ Couns; 2019 Jul; 102(7):1373-1379. PubMed ID: 30853142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer patients can be advocates for colorectal cancer screening for their siblings: A study on siblings' perspectives.
    Tan KK; Lim TZ; Chew E; Chow WM; Koh GC
    Psychooncology; 2020 Dec; 29(12):2028-2032. PubMed ID: 32715510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
    Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
    Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers of and facilitators to physician recommendation of colorectal cancer screening.
    Guerra CE; Schwartz JS; Armstrong K; Brown JS; Halbert CH; Shea JA
    J Gen Intern Med; 2007 Dec; 22(12):1681-8. PubMed ID: 17939007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do some participants in colorectal cancer screening choose not to undergo colonoscopy following a positive test result? A qualitative study.
    Bie AKL; Brodersen J
    Scand J Prim Health Care; 2018 Sep; 36(3):262-271. PubMed ID: 30238859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to colorectal cancer screening for Pakistani immigrants in Norway - a qualitative study.
    Iqbal N; Berstad P; Solbjør M; Diaz E; Czapka E; Hofvind S; Bhargava S
    BMC Health Serv Res; 2024 Jul; 24(1):799. PubMed ID: 38992652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon Cancer among Older Saudis: Awareness of Risk Factors and Early Signs, and Perceived Barriers to Screening.
    Galal YS; Amin TT; Alarfaj AK; Almulhim AA; Aljughaiman AA; Almulla AK; Abdelhai RA
    Asian Pac J Cancer Prev; 2016; 17(4):1837-46. PubMed ID: 27221862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions about cancer and barriers towards cancer screening among ethnic minority women in a deprived area in Denmark - a qualitative study.
    Tatari CR; Andersen B; Brogaard T; Badre-Esfahani SK; Jaafar N; Kirkegaard P
    BMC Public Health; 2020 Jun; 20(1):921. PubMed ID: 32532227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
    Larsen PT; Jørgensen SF; Njor SH
    BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
    Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.